Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1968 Sep;34(1):169–176. doi: 10.1111/j.1476-5381.1968.tb07960.x

Kinins and anti-inflammatory steroids

V Eisen, L Greenbaum, G P Lewis
PMCID: PMC1703412  PMID: 4175457

Abstract

1. This investigation was designed to re-examine the possibility that anti-inflammatory steroids interfere with the kinin-forming system.

2. We conclude that the anti-inflammatory action of corticosteroids cannot be explained by the inhibition of kinin formation. This view is based on the following findings.

3. Neither hydrocortisone nor prednisolone nor dexamethasone inhibited the activation or activity of intrinsic plasma kinin forming enzymes resulting from dilution, incubation with kininase inhibitors, or exposure to glass, monosodium urate microcrystals or to precipitated complexes of rheumatoid factor and aggregated human γ-globulin.

4. Hydrocortisone did not inhibit the action of the active kinin-forming enzymes, human salivary or urinary kallikrein, or plasmin on purified kininogen.

5. Hydrocortisone, prednisolone and dexamethasone did not inhibit the hydrolysis of benzoyl-arginine-ethyl ester by human plasmin, plasma kallikrein or hog pancreatic kallikrein.

6. Kinin formation occurred normally in plasma taken from two patients receiving betamethasone and one receiving prednisone.

Full text

PDF
169

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTORGA G., BOLLET A. J. DIAGNOSTIC SPECIFICITY AND POSSIBLE PATHOGENETIC SIGNIFICANCE OF INCLUSIONS IN SYNOVIAL LEUCOCYTES. Arthritis Rheum. 1965 Aug;8:511–523. doi: 10.1002/art.1780080405. [DOI] [PubMed] [Google Scholar]
  2. Brocklehurst W. E., Mawer G. E. The purification of a kininogen from human plasma. Br J Pharmacol Chemother. 1966 Aug;27(2):256–276. doi: 10.1111/j.1476-5381.1966.tb01661.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Davies G. E., Holman G., Johnston T. P., Lowe J. S. Studies on kallikrein: failure of some anti-inflammatory drugs to affect release of kinin. Br J Pharmacol Chemother. 1966 Nov;28(2):212–217. doi: 10.1111/j.1476-5381.1966.tb01887.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hochstrasser K., Werle E. Uber kininliefernde Peptide aus pepsinverdauten Rinderplasmaproteinen. Hoppe Seylers Z Physiol Chem. 1967 Feb;348(2):177–182. [PubMed] [Google Scholar]
  5. Jacobsen S. Substrates for plasma kinin-forming enzymes in human, dog and rabbit plasmas. Br J Pharmacol Chemother. 1966 Feb;26(2):403–411. doi: 10.1111/j.1476-5381.1966.tb01920.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. MARGOLIS J., BISHOP E. A. STUDIES ON PLASMA KININS. I. THE COMPOSITION OF KININOGEN COMPLEX. Aust J Exp Biol Med Sci. 1963 Aug;41:293–306. doi: 10.1038/icb.1963.29. [DOI] [PubMed] [Google Scholar]
  7. NORTHOVER B. J., SUBRAMANIAN G. Analgesic-antipyretic drugs as inhibitors of kallikrein. Br J Pharmacol Chemother. 1961 Aug;17:107–115. doi: 10.1111/j.1476-5381.1961.tb01110.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. SCHWERT G. W., TAKENAKA Y. A spectrophotometric determination of trypsin and chymotrypsin. Biochim Biophys Acta. 1955 Apr;16(4):570–575. doi: 10.1016/0006-3002(55)90280-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES